Jazz Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Jazz Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $3,834,204,000. The net income raised on $414,832,000 and profit margin reached 11%. Total operating expenses were $2,820,047,000.
Profit Margin
| 2014 | 1.17B | 58.38M | 4.98% |
|---|---|---|---|
| 2015 | 1.32B | 329.53M | 24.87% |
| 2016 | 1.48B | 396.83M | 26.67% |
| 2017 | 1.61B | 487.84M | 30.14% |
| 2018 | 1.89B | 447.09M | 23.64% |
| 2019 | 2.16B | 523.36M | 24.21% |
| 2020 | 2.36B | 238.61M | 10.1% |
| 2021 | 3.09B | -328.95M | -10.63% |
| 2022 | 3.65B | -214.13M | -5.85% |
| 2023 | 3.83B | 414.83M | 10.82% |
JAZZ Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.83B | 3.65B | 3.09B | 2.36B | 2.16B | 1.89B | 1.61B | 1.48B | 1.32B | 1.17B |
Cost of revenue | 435.57M | 540.51M | 440.76M | 148.91M | 127.93M | 121.54M | 110.18M | 105.38M | 102.52M | 117.41M |
Gross profit | 3.39B | 3.11B | 2.65B | 2.21B | 2.03B | 1.76B | 1.50B | 1.38B | 1.22B | 1.05B |
Operating exp. | ||||||||||
Research and development | 849.65M | 590.45M | 505.74M | 335.37M | 299.72M | 226.61M | 198.44M | 162.29M | 135.25M | 85.18M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.7M |
Total operating expenses | 2.82B | 2.60B | 2.48B | 1.44B | 1.39B | 1.11B | 894.66M | 767.18M | 682.53M | 617.87M |
Operating income | 578.58M | 512.26M | 170.27M | 765.46M | 532.37M | 614.83M | 528.84M | 591.65M | 508.22M | 195.58M |
Other income (expenses), net | -280.65M | -885.05M | -283.11M | -102.97M | -78.07M | -51.19M | -87.72M | -21.01M | -72.28M | -44.03M |
Income before tax | 297.92M | -372.78M | -112.83M | 275.09M | 454.30M | 529.46M | 441.11M | 532.44M | 435.93M | 151.55M |
Income tax expense | -119.91M | -158.64M | 216.11M | 33.51M | -73.15M | 80.16M | -47.74M | 135.23M | 106.39M | 94.23M |
Net income | 414.83M | -214.13M | -328.95M | 238.61M | 523.36M | 447.09M | 487.84M | 396.83M | 329.53M | 58.38M |
Earnings per share | ||||||||||
Basic EPS | 6.95 | -3.42 | -5.51 | 4.28 | 9.22 | 7.45 | 8.13 | 6.56 | 5.38 | 0.98 |
Diluted EPS | 6.1 | -3.42 | -5.51 | 4.22 | 9.09 | 7.3 | 7.96 | 6.41 | 5.23 | 0.93 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |